Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in the number of shares and votes in Gunnebo

During the month of July, 128,580 series C shares, which previously have been issued and repurchashed within the context of Gunnebo’s long-term incentive program as resolved by the Annual General Meeting 2015 (LTIP 2015), have been converted into ordinary shares. The number of ordinary shares has thus increased by 128,580 and the number of series C shares has decreased by as many shares. The number of votes has increased by 115,722. As of 31 July 2018, the total number of shares in the company still amounts to 77,050,848, of which 602,267 series C shares and 76,448,581 ordinary shares.

Allgon completes the acquisition of Tele Radio

Allgon AB (publ) (“Allgon” or the “Company”) has today completed the acquisition of all shares in Tele-Radio International Holding AB (“Tele Radio”), which was announced on 4 May 2018, for a purchase price of SEK 350 million on a debt and cash free basis with a possible additional purchase price of up to a maximum of SEK 50 million (the “Transaction”).The Transaction has been financed partly through the recent issues in Allgon of corporate bonds of SEK 276 million and a rights issue of class B shares of approximately SEK 127 million, partly through an in-kind share issue of 9,780,707 class

Archer Limited : Announcement of second quarter 2018 earnings release date and conference call information

Hamilton, Bermuda (July 31, 2018) Archer Limited's second quarter 2018 earnings are scheduled to be released on August 14, 2018 before the start of trading on Oslo Stock Exchange.  In connection with the earnings release, a conference call will be held at 8:00am London time, 9:00am Oslo time on August 14, 2018. To listen to the conference call, the following options are available: A. Webcast To register for the webcast please go to https://edge.media-server.com/m6/p/7gkjtofg B. Conference call To access the call, which is open to the public, please contact the conference

Follicum AB receives Notice of Allowance from the U.S. Patent Office for Enhanced Protection of Product Candidate FOL-005

Follicum AB ("Follicum") announces that the U.S. Patent Office (USPTO) has issued a Notice of Allowance for their patent application 15/184,290 which is the company’s second, follow-up application which when granted confers expanded protection for Follicum's product candidate FOL-005.Follicum has already an approved US patent in this patent family, specifically covering FOL-005. Follicum has subsequently submitted a follow-up application, called Continuing Patent Application, which extends the protection around FOL-005 for which Follicum now has received a Notice of Allowance. Notice of

Announcement of change in the total number of votes in AB SKF

Gothenburg 31 July 2018: Due to a conversion of shares from Series A to Series B in accordance with the Company’s Articles of Association, AB SKF confirms the following.  As per 31 July the Company’s share capital amounts to SEK 1,138,377,670 and the total number of shares amounts to 34,055,803 shares of Series A and 421,295,265 shares of Series B. The number of votes in the Company amounts to 76,185,330.  AB SKF does not hold any own shares. The information in this press release is information which AB SKF is required to disclose under the EU Market Abuse Regulation (EU) No 596/2014 The

Change in number of shares and votes in ÅF AB (publ)

The second opportunity to convert debentures into shares under the staff convertible debenture program decided by the Annual General Meeting 2015 occurred in July 2018. Through the conversion the numbers of B-shares and votes have increased by 71 583. Before the conversion: A-shares: 3 217 752B-shares: 75 546 319Total shares: 78 764 071Votes: 107 723 839 After the conversion: A-shares: 3 217 752B-shares: 75 617 902Total shares: 78 835 654Votes: 107 795 422 Please note that the numbers of shares and votes registered with the

Scientific study shows that GARDskin™ is the most accurate test for skin sensitization of chemical substances

Lund, 31 July 2018 – SenzaGen (Nasdaq First North: SENZA) announces today that a new scientific study shows that GARDskin™ can provide producers and contract laboratories with a single test for evaluating substances, with an increased accuracy as compared with the recommended combination of current market leading methods. The reason for this recommendation by regulatory authorities is the relatively low accuracy of the currently available individual methods. The positive results from the published study shows that GARDskin™ could be established as the first animal-free standalone test and

Ahlstrom-Munksjö Oyj: Managers' Transactions (Hans Sohlström)

AHLSTROM-MUNKSJÖ OYJ, MANAGERS’ TRANSACTION RELEASE July 31, 2018 at 9:45 EEST ____________________________________________ Person subject to the notification requirementName: Hans SohlströmPosition: Chief Executive OfficerIssuer: Ahlström-Munksjö OyjLEI: 213800F2MJ5Z2TAQ1726 Notification type: INITIAL NOTIFICATIONReference number: 213800F2MJ5Z2TAQ1726_20180731090300_2____________________________________________ Transaction date: 2018-07-30Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000048418Nature of the transaction: ACQUISITION

YIT Corporation: Managers’ transactions

YIT Corporation, Managers’ transactions, July 31, 2018 at 09:40 a.mYIT Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Harri-Pekka Kaukonen Position: Member of the Board/Deputy member Issuer: YIT Oyj LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20180731092351_6 ____________________________________________ Transaction date: 2018-07-30 Venue: BATS CHI-X EUROPE -BXE ORDER BOOKS (BATE) Instrument type: SHARE ISIN:

NextCell Pharma publishes quarterly report three 2017/2018

NextCell Pharma AB (”NXTCL”, “NextCell”) today, released its third quarter report 2017/2018(September 2017 – May 2018).Nine Months (2017-09-01 until 2018-05-31)  · Net sales amounted to SEK 527 545 (318 438). · Operating result amounted to SEK -10 610 012 (-8 477 749).                      · Result per share* amounted to SEK -1,25 (-2,89). · Cash and bank amounted to SEK 5 929 492 (6 558 898). · Solidity amounted to 83.8 (70.4)%. · Net sales amounted to SEK 136 341 (197 846). · Operating result amounted to SEK -3 085 756 (-3 614 243).                        ·

Changes in NOTE’s Nomination Committee and the Chairman of the Board, John Hedberg, has decided to withdraw from the Board

According to the decision by the Annual General Meeting (AGM), the members of the Nomination Committee should be appointed by the four shareholders having the largest holdings in NOTE and which desire to appoint a representative. On account of changes within the ownership structure, there are consequently changes in the composition of the Nomination Committee. The Nomination Committee now comprises of:- Johan Hagberg, own holdings- Martin Nilsson, Catella Fondförvaltning- Malin Björkmo, Handelsbanken Fonder- Gunnar Blix, Tredje AP-fonden The Nomination Committee is appointed

Triton has signed an agreement to acquire SKF Motion Technologies

Stockholm (Sweden), Gothenburg (Sweden) 31 July 2018 – Funds advised by Triton (“Triton”) have signed an agreement of its intention to acquire the business unit SKF Motion Technologies from SKF Group, listed on Nasdaq Stockholm. Triton intends to form a standalone company under a new brand.Regulatory approvals, finalization of necessary consultations and other customary closing conditions are underway. SKF’s French linear and actuation technology business is dealt with on a separate process, but both parties have the intention to reach an agreement to also divest it to Triton. SKF Motion

Aker BP acquires licence portfolio from Total

Aker BP has entered into an agreement with Total E&P Norge to acquire its interests in a portfolio of 11 licences on the Norwegian Continental Shelf for a cash consideration of USD 205 million. The portfolio includes four discoveries with net recoverable resources of 83 million barrels oil equivalents ("mmboe"), based on estimates from the Norwegian Petroleum Directorate. Two of the discoveries, Trell and Trine, are located near the Aker BP-operated Alvheim field and are expected to be produced through the Alvheim FPSO. The Alve Nord discovery is located north of the Aker BP-operated

Number of shares and votes in Calliditas Therapeutics

During July, the number of shares and votes in Calliditas Therapeutics AB (publ) (the “Company”) has increased due to the issue of 1,970,000 new shares that the Company carried out pursuant to the utilization of the over-allotment option that the Company granted in order to cover any over-allotment in the offering of shares in connection with the listing of the Company’s shares on Nasdaq Stockholm. As of July 31, 2018, the number of shares and votes in the Company is 35,202,347.For further information, please contact: Renée Aguiar-Lucander, CEO at Calliditas Email: renee.lucander@

DDM Holding AG: Q2 and half year report January - June 2018

Significant increase of collections from portfoliosHighlights second quarter 2018 · Net collections increased by 55% to EUR 15.5M (Q2 2017: EUR 10.0M) · Cash EBITDA increased by 53% and amounted to EUR 13.8M (Q2 2017: EUR 9.0M) · Net profit for the period of EUR 1.0M (Q2 2017: profit of EUR 0.7M) · Gross ERC at the end of June 2018 was EUR 269M, an increase of 209% (Q2 2017: EUR 87M) · Investments in the Czech Republic and the Balkans totaling approximately EUR 6M Highlights six months 2018 · Net collections increased by 45% to EUR 26.2M (H1 2017: EUR 18.1M) ·

Essity restructures in France

To further strengthen competitiveness and increase efficiency, Essity is restructuring its Consumer Tissue production in France.Essity is closing a converting facility for retail branded products in Saint-Etienne-du-Rouvray and invests in remaining integrated production facilities in France. The closure is expected during the fourth quarter of 2018. These measures are aligned with the company’s strategy to optimize the production footprint to increase cost and capital efficiency and further increase value creation in the Consumer Tissue business area. The restructuring costs are expected

Double Bond Pharmaceutical receives patent in the United States for the BeloGal® platform

Double Bond Pharmaceuticals patent application for organ-specific administration of hydrophilic cancer drug to the liver which forms the basis for the BeloGal® technology platform has been granted in the United States. Patent approval provides protection for the technology platform BeloGal® and products on the US market at least through 2035. "It is the company's first licensed patent and we are very pleased that it concerns the largest market in the world - the United States. With the patent, we have achieved an important interim goal for the commercialization of our front-line product

Increase of number of shares and votes in Hansa Medical AB (publ)

As previously announced, the general meeting of Hansa Medical AB (publ) resolved to adopt a warrant program 2015-2019 on June 2, 2015. As part of the completion of the program, 50,000 ordinary shares have been issued. The company’s registered share capital and number of outstanding shares and votes have thus increased during the month of July 2018.As of today, the total number of registered and outstanding shares of Hansa Medical amounts to 38,463,386 whereof 38,133,125 are ordinary shares and 330,261 are Class C shares. As of today, the number of votes in Hansa Medical amounts to 38,166,

DDM Debt AB: Q2 and half year report January - June 2018

Significant increase of collections from portfoliosHighlights second quarter 2018 · Net collections increased by 57% to EUR 15.4M (Q2 2017: EUR 9.8M) · Cash EBITDA increased by 67% to EUR 13.7M (Q2 2017: EUR 8.2M) · Net profit for the period of EUR 0.6M (Q2 2017: loss of EUR 0.0M) · Investments in the Czech Republic and the Balkans totaling approximately EUR 6M Highlights six months 2018   · Net collections increased by 64% to EUR 25.9M (H1 2017: EUR 15.8M) · Cash EBITDA increased by 72% to EUR 22.5M (H1 2017: EUR 13.1M) · Net profit for the period of EUR 1.5M (

Hexagon Interim Report 1 January - 30 June 2018

Second quarter 2018- Operating net sales increased by 7 per cent to 936.9 MEUR (872.0). Using fixed exchange rates and a comparable group structure (organic growth), net sales increased by 9 per cent- Operating earnings (EBIT1) increased by 11 per cent to 228.2 MEUR (205.3)- Earnings before taxes, excluding non-recurring items, amounted to 222.8 MEUR (200.0)- Net earnings, excluding non-recurring items, amounted to 182.7 MEUR (164.3)- Earnings per share, excluding non-recurring items, increased by 11 per cent to 0.50 EUR (0.45)- Operating cash flow increased by 23 per cent to

Number of shares and votes in Internationella Engelska Skolan

During July, the number of shares and votes in Internationella Engelska Skolan i Sverige Holdings II AB (publ) (“IES”) has changed as a result of the issue and repurchase of 80,000 class C shares as announced on July 2, 2018. Today, the last trading day of the month, there are in total 40,130,000 shares - whereof 40,050,000 are ordinary shares and 80,000 are class C shares - and 40,058,000 votes in IES. For more information, please contact:Johan Hähnel, IES‘s IR Manager         Tel: +46 (0)70 605 6334 e-mail: johan.hahnel@engelska.se The information in the press release is

SKF divests linear and actuation technology business

Gothenburg, 31 July 2018: SKF has signed an agreement to divest its linear and actuation technology business to Triton. The total consideration of the deal is SEK 2.75 billion, on a cash- and debt free basis and it is expected to close during the end of 2018. The divestment is subject to regulatory approvals and involves consultation with employee representative bodies. Christian Johansson, Senior Vice President and CFO, says: “Having successfully developed this as a stand-alone entity, it will now have an ownership structure that is able to invest in its continued development. The

More from the Company Monthly Newsletter July 2018

The month of July was marked by our first distribution agreement that was signed with Leib Medical Ltd. for the United Kingdom and Ireland, face-to-face meetings with potential distributors and an all-day meeting together with the General Assembly of Euro-HYP-1 in Copenhagen.QuickCool and Leib Medical Ltd. signed the first distribution agreement at the office in Lund.Leib Medical takes responsibility for launching, marketing and selling the QuickCool© SYSTEM as well as for service, maintenance and training of the same on the important Irish and British markets. With an already established

Psyonix, acclaimed video-game developer, selects Nepa for Global Brand Measurement Insights

Nepa will measure brand KPIs of Rocket League® and Psyonix sponsorships on a continuous basis in five strategic markets – US, UK, Germany, France, and Spain.July 31th, 2018 New York, NY Nepa US Inc. announces today that they have been selected by Psyonix to provide Brand & Ad Tracking research for acclaimed video-game Rocket League and Psyonix strategic partnerships. The partnership will begin immediately with a strategic brand positioning analysis for Rocket League and key competitors. Through its Consumer Science Platform, Nepa will connect continuous measurement of key metrics such

There are no items matching the current filter
There are no more items matching the current filter
Back to top